Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.
Int J Mol Sci. 2022 Jan 27;23(3):1478. doi: 10.3390/ijms23031478.
Int J Mol Sci. 2022.
PMID: 35163401
Free PMC article.
Review.
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study.
Sankaranarayanan RA, Peil J, Vogg ATJ, Bolm C, Terhorst S, Classen A, Bauwens M, Maurer J, Mottaghy F, Morgenroth A.
Sankaranarayanan RA, et al. Among authors: peil j.
Cancers (Basel). 2022 Jan 4;14(1):230. doi: 10.3390/cancers14010230.
Cancers (Basel). 2022.
PMID: 35008392
Free PMC article.
Item in Clipboard
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230.
Sankaranarayanan RA, Peil J, Vogg ATJ, Bolm C, Terhorst S, Classen A, Bauwens M, Maurer J, Mottaghy F, Morgenroth A.
Sankaranarayanan RA, et al. Among authors: peil j.
Cancers (Basel). 2023 May 6;15(9):2641. doi: 10.3390/cancers15092641.
Cancers (Basel). 2023.
PMID: 37174130
Free PMC article.
Item in Clipboard
Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
Peil J, Vossen C, Bock F, Clahsen T, Schiller P, Heindl LM, Bosch JJ, Wunderlich FT, Cursiefen C, Schlereth SL.
Peil J, et al.
J Immunol. 2024 Feb 1;212(3):487-499. doi: 10.4049/jimmunol.2300063.
J Immunol. 2024.
PMID: 38099710
Item in Clipboard
Cite
Cite